Close Menu

Proteome Sciences

Proteome Sciences this week reported full-year 2012 revenues of £1.2 million ($1.8 million), up 13 percent from £1 million in 2011.

Shimadzu this week announced the launch of its Imaging Mass Microscrope, iMScope, which combines optical microscopy and mass spectrometry in one instrument.

Proteome Sciences said this week that its SensiDerm multiplex protein assays for detection of sensitizers and allergens in cosmetics have been prioritized for further development by Cosmetics Europe, the European trade organization for the cosmetics, toiletry, and perfumery indus

Proteome Sciences said this week that it has completed an in vivo study of its CK1D-inhibitor Alzheimer's disease therapy, finding that both of its lead compounds improved cognitive function in animal models.

According to a team led by researchers at Plymouth University, there are significant flaws in the standard cognitive test used to diagnose and evaluate Alzheimer's disease patients, which could be hampering efforts to develop treatments and biomarkers for the disease.

Researchers from the University of Wisconsin-Madison have characterized the mitochondrial acetylome, finding significant changes in protein acetylation in response to calorie restriction and activity of the protein deacetylase SIRT3.

Last month, a research team led by Bruno Domon, head of the Luxembourg Clinical Proteomics Center, published a paper in Molecular & Cellular Proteomics demonstrating

University of Geneva researchers in collaboration with the UK's Proteome Sciences have identified a protein marker that could help doctors better determine the time of stroke onset.

NEW YORK (GenomeWeb News) – Proteome Sciences today said that revenues during the first half of 2012 rose 44 percent year over year.

NEW YORK (GenomeWeb News) – Proteome Sciences said today that it will collaborate with CHDI Foundation on research into protein biomarkers for Huntington's disease.

Pages

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.